Invention Grant
- Patent Title: Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
-
Application No.: US14679651Application Date: 2015-04-06
-
Publication No.: US09671411B2Publication Date: 2017-06-06
- Inventor: Stephen Poole , Mehul Patel
- Applicant: BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE SA , THE SECRETARY OF STATE FOR HEALTH
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon) GB London
- Assignee: BAXTER INTERNATIONAL INC.,BAXTER HEALTHCARE SA,THE SECRETARY OF STATE FOR HEALTH
- Current Assignee: BAXTER INTERNATIONAL INC.,BAXTER HEALTHCARE SA,THE SECRETARY OF STATE FOR HEALTH
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon) GB London
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: G01N33/00
- IPC: G01N33/00 ; G01N33/68 ; G01N33/50

Abstract:
An improved monocyte activation test is described that is better able to detect non-endotoxin pyrogens in medical products, in which a sample is incubated with a monocyte-containing reagent in an assay system comprising at least one surface comprising polypropylene. The invention also concerns assay systems for use in these tests that include at least one microtiter well having at least one interior surface comprising polypropylene and having a shape such that monocyte-containing reagent is concentrated in the well to provide greater cell to cell contact. The invention also relates to a diagnostic kit that can be used to test for the presence of non-endotoxin pyrogens in a sample.
Public/Granted literature
- US20150285819A1 MONOCYTE ACTIVATION TEST BETTER ABLE TO DETECT NON-ENDOTOXIN PYROGENIC CONTAMINANTS IN MEDICAL PRODUCTS Public/Granted day:2015-10-08
Information query